Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | MTX-1000 |
| Synonyms | |
| Therapy Description |
MTX-1000 is an antibody-drug conjugate (ADC) comprising an ERBB2 (HER2) antibody linked to exatecan, which upon internalization may result in tumor cell killing and decreased growth of ERBB2 (HER2)-expressing tumors (PMID: 36693125). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| MTX-1000 | MTX1000|MTX 1000 | HER2 (ERBB2) Antibody-Drug Conjugate 35 | MTX-1000 is an antibody-drug conjugate (ADC) comprising an ERBB2 (HER2) antibody linked to exatecan, which upon internalization may result in tumor cell killing and decreased growth of ERBB2 (HER2)-expressing tumors (PMID: 36693125). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|